Search Results

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

Meta-Analysis of Antidepressant Augmentation: Piling on in the Absence of Evidence

Authors: Yury, Craig A.; Fisher, Jane E.; Antonuccio, David O.; Valenstein, Marcia; Matuszak, Jeremy

Source: Ethical Human Psychology and Psychiatry, Volume 11, Number 3, 2009 , pp. 171-182(12)

Publisher: Springer Publishing Company

Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Authors: Bhuvaneswar, Chaya G.; Baldessarini, Ross J.; Harsh, Veronica L.; Alpert, Jonathan E.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1003-1021(19)

Publisher: Adis International

Antidepressants for neuroenhancement in healthy individuals: a systematic review

Authors: Repantis, Dimitris; Schlattmann, Peter; Laisney, Oona; Heuser, Isabella

Source: Poiesis & Praxis, Volume 6, Numbers 3-4, August 2009 , pp. 139-174(36)

Publisher: Springer

Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications

Authors: Dremencov, Eliyahu; Mansari, Mostafa e.; Blier, Pierre

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1061-1068(8)

Publisher: Bentham Science Publishers

The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)

Authors: Ruf, B. M.; Bhagwagar, Z.

Source: Current Drug Targets, Volume 10, Number 11, November 2009 , pp. 1118-1138(21)

Publisher: Bentham Science Publishers

Acceptance of and Discontinuation Rate from Paroxetine Treatment in Patients with Lifelong Premature Ejaculation

Authors: Salonia, Andrea; Rocchini, Lorenzo; Sacca', Antonino; Pellucchi, Federico; Ferrari, Matteo; Carro, Ubaldo Del; Ribotto, Paolo; Gallina, Andrea; Zanni, Giuseppe; Deho', Federico; Rigatti, Patrizio; Montorsi, Francesco

Source: The Journal of Sexual Medicine, Volume 6, Number 10, October 2009 , pp. 2868-2877(10)

Publisher: Blackwell Publishing

Emerging drugs for major depressive disorder

Authors: Kennedy, Sidney H; Rizvi, Sakina J

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 3, September 2009 , pp. 439-453(15)

Publisher: Informa Healthcare

Update on smoking cessation therapies

Authors: Glynn, Deirdre; Cryan, John; Kent, Pauline; Flynn, Robert; Kennedy, Marcus

Source: Advances in Therapy, Volume 26, Number 4, April 2009 , pp. 369-382(14)

Publisher: Springer

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Authors: Paschos, Konstantinos A.; Veletza, Stavroula; Chatzaki, Ekaterini

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 755-772(18)

Publisher: Adis International

The Use of Selective Serotonin Reuptake Inhibitors in Elderly Patients

Authors: Chemali, Zeina; Chahine, Lama; Fricchione, Gregory

Source: Harvard Review of Psychiatry, Volume 17, Number 4, August 2009 , pp. 242-253(12)

Publisher: Informa Healthcare

Agomelatine: Innovative Pharmacological Approach in Depression

Author: Popoli, Maurizio

Source: CNS Drugs, Volume 23, Supplement 2, 1 September 2009 , pp. 27-34(8)

Publisher: Adis International

Self-poisoning in older adults: patterns of drug ingestion and clinical outcomes

Authors: Doak, Martin W.; Nixon, Andrew C.; Lupton, David J.; Waring, W. Stephen

Source: Age and Ageing, Volume 38, Number 4, 22 July 2009 , pp. 407-411(5)

Publisher: Oxford University Press

Advances in the treatment of menopausal symptoms

Authors: Pinkerton, JoAnn V; Stovall, Dale W; Kightlinger, Rebecca S

Source: Women's Health, Volume 5, Number 4, July 2009 , pp. 361-384(24)

Publisher: Future Medicine

Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms

Authors: Kurian, Benji T; Greer, Tracy L; Trivedi, Madhukar H

Source: Expert Review of Neurotherapeutics, Volume 9, Number 7, July 2009 , pp. 975-984(10)

Publisher: Expert Reviews

σ-1 receptors in major depression and anxiety

Authors: Kulkarni, Shrinivas K; Dhir, Ashish

Source: Expert Review of Neurotherapeutics, Volume 9, Number 7, July 2009 , pp. 1021-1034(14)

Publisher: Expert Reviews

Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants

Authors: Pae, Chi-Un; Marks, David M; Patkar, Ashwin A; Masand, Prakash S; Luyten, Patrick; Serretti, Alessandro

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 10, July 2009 , pp. 1561-1570(10)

Publisher: Informa Healthcare

Current investigational drugs for major depression

Authors: Kulkarni, Shrinivas K; Dhir, Ashish

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 767-788(22)

Publisher: Informa Healthcare

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1559-1562(4)

Publisher: Bentham Science Publishers

Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today

Authors: Lopez-Munoz, Francisco; Alamo, Cecilio

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1563-1586(24)

Publisher: Bentham Science Publishers